# US 2021/0343414 A1 · Methods and apparatus for phenotype-driven clinical genomics using a likelihood ratio paradigm

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0343414 A1
- Document ID: US20210343414A1
- Status: Published application
- Kind: A1
- Application number: 17/285,435
- Filed: 2019-10-21
- Published: 2021-11-04
- Earliest claimed: 2018-10-22
- Assignees: The Jackson Laboratory
- Applicants: The Jackson Laboratory
- Inventors: Peter N. Robinson
- Web page: https://patentgrep.com/patent/US20210343414A1

## CPC

- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 50/50: for simulation or modelling of medical disorders
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

Methods and apparatus for providing clinical decision support. The method comprises receiving phenotype information for a patient, determining a likelihood ratio for each of the phenotype features included in the received phenotype information with respect to each of a plurality of diseases, determining, based on the likelihood ratio for each of the phenotype features, a composite likelihood ratio for each of the plurality of diseases, ranking the plurality of diseases based, at least in part, on the determined composite likelihood ratios, and displaying at least some of the ranked plurality of diseases.

## Claims

### Claim 1

A clinical decision support system, comprising:
at least one computer processor; and
at least one storage device having stored thereon, a plurality of computer-readable instructions that, when executed by the at least one computer processor performs a method comprising:
receiving phenotype information for a patient;
determining a likelihood ratio for each of the phenotype features included in the received phenotype information with respect to each of a plurality of diseases;
determining, based on the likelihood ratio for each of the phenotype features, a composite likelihood ratio for each of the plurality of diseases;
ranking the plurality of diseases based, at least in part, on the determined composite likelihood ratios; and
displaying at least some of the ranked plurality of diseases.

### Claim 2 (depends on 1)

The clinical decision support system of claim 1, wherein the method further comprises:
determining, based on the determined composite likelihood ratios, a posttest probability that the patient has each of the plurality of diseases, and
wherein ranking the plurality of diseases based, at least in part, on the determined composite likelihood ratios comprises ranking the plurality of diseases based, at least in part, on the determined posttest probabilities.

### Claim 3 (depends on 2)

The clinical decision support system of claim 2, wherein the method further comprises:
displaying information describing a contribution of one or more of the phenotype features to the determined posttest probability for each of the displayed plurality of diseases.

### Claim 4 (depends on 1)

The clinical decision support system of claim 1, wherein the method further comprises:
determining treatment recommendation information based, at least in part, on the highest ranked disease of the plurality of ranked diseases; and
providing the determined treatment recommendation information to a user.

### Claim 5 (depends on 2)

The clinical decision support system of claim 2, wherein the method further comprises:
receiving genotype information for the patient; and
determining the posttest probability based on the received genotype information.

### Claim 6 (depends on 5)

The clinical decision support system of claim 5, wherein the method further comprises:
displaying information describing a contribution of the genotype information to the determined posttest probability for each of the displayed plurality of diseases.

### Claim 7 (depends on 5)

The clinical decision support system of claim 5, wherein the genotype information comprises gene sequence information for the patient.

### Claim 8 (depends on 7)

The clinical decision support system of claim 7, wherein the method further comprises;
estimating a pathogenicity of a gene variant included in the gene sequence, wherein estimating the pathogenicity of the gene variant is based on a computational pathogenicity score for the gene variant.

### Claim 9 (depends on 2)

The clinical decision support system of claim 2, wherein method further comprises:
determining a likelihood ratio for a genotype included in the received genotype information with respect to each of the plurality of diseases, and
wherein determining the posttest probability based on the received genotype information comprises determining the posttest probability based on the determined likelihood ratio for the genotype.

### Claim 10 (depends on 9)

The clinical decision support system of claim 9, wherein the method further comprises:
determining a combined genotype-phenotype likelihood ratio score based on the determined likelihood ratio for the genotype and the determined likelihood ratio for the phenotype features, and
wherein a posttest probability that the patient has each of the plurality of diseases comprises determining the posttest probability based on the combined genotype-phenotype likelihood score.

### Claim 11

A method of providing clinical decision support, the method comprising:
receiving phenotype information for a patient;
determining a likelihood ratio for each of the phenotype features included in the received phenotype information with respect to each of a plurality of diseases;
determining, based on the likelihood ratio for each of the phenotype features, a composite likelihood ratio for each of the plurality of diseases;
ranking the plurality of diseases based, at least in part, on the determined composite likelihood ratios; and
displaying at least some of the ranked plurality of diseases.

### Claim 12 (depends on 11)

The method of claim 11, further comprising:
determining, based on the determined composite likelihood ratios, a posttest probability that the patient has each of the plurality of diseases, and
wherein ranking the plurality of diseases based, at least in part, on the determined composite likelihood ratios comprises ranking the plurality of diseases based, at least in part, on the determined posttest probabilities.

### Claim 13 (depends on 12)

The method of claim 12, further comprising:
displaying information describing a contribution of one or more of the phenotype features to the determined posttest probability for each of the displayed plurality of diseases.

### Claim 14 (depends on 11)

The method of claim 11, further comprising:
determining treatment recommendation information based, at least in part, on the highest ranked disease of the plurality of ranked diseases; and
providing the determined treatment recommendation information to a user.

### Claim 15 (depends on 12)

The method of claim 12, further comprising:
receiving genotype information for the patient; and
determining the posttest probability based on the received genotype information.

### Claim 16 (depends on 15)

The method of claim 15, further comprising:
displaying information describing a contribution of the genotype information to the determined posttest probability for each of the displayed plurality of diseases.

### Claim 17 (depends on 15)

The method of claim 15, wherein the genotype information comprises gene sequence information for the patient.

### Claim 18 (depends on 16)

The method of claim 16, further comprising;
estimating a pathogenicity of a gene variant included in the gene sequence, wherein estimating the pathogenicity of the gene variant is based on a computational pathogenicity score for the gene variant.

### Claim 19 (depends on 12)

The method of claim 12, further comprising:
determining a likelihood ratio for a genotype included in the received genotype information with respect to each of the plurality of diseases, and
wherein determining the posttest probability based on the received genotype information comprises determining the posttest probability based on the determined likelihood ratio for the genotype.

### Claim 20 (depends on 19)

The method of claim 19, further comprising:
determining a combined genotype-phenotype likelihood ratio score based on the determined likelihood ratio for the genotype and the determined likelihood ratio for the phenotype features, and
wherein a posttest probability that the patient has each of the plurality of diseases comprises determining the posttest probability based on the combined genotype-phenotype likelihood score.

### Claim 21

A non-transitory computer readable medium encoded with a plurality of instructions that, when executed by at least one computer processor perform a method, the method comprising:
receiving phenotype information for a patient;
determining a likelihood ratio for each of the phenotype features included in the received phenotype information with respect to each of a plurality of diseases;
determining, based on the likelihood ratio for each of the phenotype features, a composite likelihood ratio for each of the plurality of diseases;
ranking the plurality of diseases based, at least in part, on the determined composite likelihood ratios; and
displaying at least some of the ranked plurality of diseases.

### Claim 22 (depends on 21)

The non-transitory computer readable medium of claim 21, wherein the method further comprises:
determining, based on the determined composite likelihood ratios, a posttest probability that the patient has each of the plurality of diseases, and
wherein ranking the plurality of diseases based, at least in part, on the determined composite likelihood ratios comprises ranking the plurality of diseases based, at least in part, on the determined posttest probabilities.

### Claim 23 (depends on 22)

The non-transitory computer readable medium of claim 22, wherein the method further comprises:
receiving genotype information for the patient; and
determining the posttest probability based on the received genotype information.

### Claim 24 (depends on 23)

The non-transitory computer readable medium of claim 23, wherein the method further comprises:
displaying information describing a contribution of the genotype information to the determined posttest probability for each of the displayed plurality of diseases.
